Novartis AG (NVS) NYSE
155.08
+2.33(+1.53%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
155.08
+2.33(+1.53%)
Currency In USD
| Market Cap | 267.32B |
| Enterprise Value | 292.92B |
| P/E Ratio | 20.97 |
| PEG Ratio | -10.26 |
| Price/Sales Ratio | 5.21 |
| Price/Book Ratio | 6.37 |
| Enterprise/Revenue | 5.66 |
| Enterprise/EBITDA | 13.98 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.25 |
| Operating Margin | 0.31 |
| Return On Assets | 0.12 |
| Return On Equity | 0.33 |
| Revenue | 54.81B |
| Revenue/Share | 29.41 |
| Gross Profit | 41.12B |
| EBITDA | 22.99B |
| Net Income | 14.06B |
| Diluted EPS | 7.19 |
| Total Cash | 11.59B |
| Total Cash/Share | 6.05 |
| Total Debt | 37.11B |
| Total Debt/Equity | 0.8 |
| Current Ratio | 1.12 |
| Book Value Per Share | 24.32 |
| 52-Week Change | 40 |
| 52-Week High | 170.46 |
| 52-Week Low | 97.72 |
| Moving Average 50 Days | 156.02 |
| Moving Average 200 Days | 134.39 |
| Average Volume | 2.36M |
| Shares Outstanding | 1.93B |
| % Held by Institutions | 7.21 |
| Trailing Annual Dividend Rate | 3.01 |
| Trailing Annual Dividend Yield | 1.96 |
| Payout Ratio | 0.54 |
| Last Split Factor | 279:250 |
| Last Split Date | April 09, 2019 |